The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomized controlled VaSera trial
Abstract
Aims: The aims of the present study were to explore whether a long‐term intervention with dietary nitrate [(NO 3−), a potential tolerance‐free source of beneficial vasoactive nitric oxide] and spironolactone (to oppose aldosterone's potential deleterious cardiovascular effects) improve cardiac structure/function, independently of blood pressure (BP), in patients with/at risk of type 2 diabetes (a population at risk of heart failure). Methods: A subsample of participants in our double‐blind, randomized, factorial‐design intervention (VaSera) trial of active beetroot juice as a nitrate source (≤11.2 mmol) or placebo (nitrate depleted) beetroot juice, and either ≤50 mg spironolactone or ≤16 mg doxazosin (control), had transthoracic cardiac ultrasounds at baseline (n = 105), and at 3 months and 6 months (n = 87) after the start of the intervention. Analysis was by modified intent‐to‐treat. Results: Nitrate‐containing juice (n = 40) decreased left ventricular (LV) end‐diastolic volume {−6.3 [95% confidence interval (CI) –11.1, –1.6] ml} and end‐systolic volume [−3.2 (95% CI −5.9, –0.5) ml], and increased end‐diastolic mass/volume ratio [+0.04 (95% CI 0.00, 0.07)], relative to placebo juice (n = 47). Spironolactone (n = 44) reduced relative wall thickness compared with doxazosin (n = 43) [−0.01 (95% CI −0.02, –0.00)]. Although spironolactone reduced LV mass index relative to baseline [−1.48 (95% CI −2.08, –0.88) g m–2.7], there was no difference vs. doxazosin [−0.85 (95% CI −1.76, 0.05) g m–2.7]. Spironolactone also decreased the E/A ratio [−0.12 (95% CI −0.19, –0.04)] and increased S′ (a tissue‐Doppler systolic function index) by 0.52 (95% CI 0.05, 1.0) cm s–1. BP did not differ between the juices, or between the drugs. Conclusions: Six months' dietary nitrate decreased LV volumes ~5%, representing new, sustained, BP‐independent benefits on cardiac structure, extending mechanisms characterized in preclinical models of heart failure. Spironolactone's effects on cardiac remodelling and systolic–diastolic function, although confirmatory, were independent of BP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this effect appears to be more limited in hypertensive individuals [121][122][123][124][125].”
From Nitrate and nitrite bioavailability in plasma and saliva: their association with blood pressure - A systematic review and meta-analysis. (2025) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Webb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N., & Ahluwalia, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402927101 · Cited by 608
Self-citationCavender, M. A., Steg, P. G., Smith, S. C., Eagle, K., Ohman, E. M., Goto, S., Kuder, J., Im, K., Wilson, P. W. F., & Bhatt, D. L. (2015) · Circulation · doi:10.1161/circulationaha.114.014796 · Cited by 501
Kapil, V., Khambata, R. S., Robertson, A., Caulfield, M. J., & Ahluwalia, A. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04675 · Cited by 500
Lidder, S., & Webb, A. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04420.x · Cited by 360
Self-citationEffect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Zamani, P., Rawat, D., Shiva-Kumar, P., Geraci, S., Bhuva, R., Konda, P., Doulias, P.-T., Ischiropoulos, H., Townsend, R. R., Margulies, K. B., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012957 · Cited by 307
Gilchrist, M., Winyard, P. G., Aizawa, K., Anning, C., Shore, A., & Benjamin, N. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.024 · Cited by 261
Eggebeen, J., Kim-Shapiro, D. B., Haykowsky, M., Morgan, T. M., Basu, S., Brubaker, P., Rejeski, J., & Kitzman, D. W. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.12.013 · Cited by 190
A comparison of organic and inorganic nitrates/nitrites
Omar, S. A., Artime, E., & Webb, A. J. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.008 · Cited by 106
Self-citationShepherd, A. I., Gilchrist, M., Winyard, P. G., Jones, A. M., Hallmann, E., Kazimierczak, R., Rembialkowska, E., Benjamin, N., Shore, A. C., & Wilkerson, D. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.014 · Cited by 69
Research works printed but not linked: 45
- 10.1186/1475-2840-8-15 · DOI
- 10.1016/j.numecd.2008.12.009 · DOI
- 10.1093/nar/gkx1121 · DOI · Paper page
- 10.1111/bph.13354 · DOI · Paper page
- Jin RC, 2010, Vascular nitric oxide: formation and function, J Blood Med, 2010, 147
- 10.1111/j.1463-1326.2007.00803.x · DOI
- 10.1016/j.amjcard.2016.08.077 · DOI
- 10.1056/NEJMoa1510774 · DOI · Paper page
- Webb A, 2010, Nitric Oxide (Second Edition). Biology and Pathobiology, 555
- 10.3945/ajcn.115.116244 · DOI · Paper page
- 10.1111/bcp.12913 · DOI
- 10.1161/HYPERTENSIONAHA.107.103523 · DOI · Paper page
- 10.1016/j.niox.2017.05.005 · DOI
- 10.1016/j.jacc.2017.07.765 · DOI
- 10.1111/bcp.12918 · DOI
- 10.1161/CIRCULATIONAHA.114.009554 · DOI
- 10.1016/j.jacc.2017.10.093 · DOI
- 10.1161/CIRCRESAHA.116.305082 · DOI
- 10.1093/eurheartj/ehu096 · DOI
- 10.1111/bcp.13231 · DOI
- 10.1161/CIRCRESAHA.114.303822 · DOI · Paper page
- 10.1161/JAHA.116.003551 · DOI
- 10.1161/01.CIR.92.2.175 · DOI · Paper page
- 10.1111/bph.13352 · DOI · Paper page
- 10.1016/j.jacc.2009.03.066 · DOI · Paper page
- 10.1016/j.artres.2015.10.194 · DOI
- 10.1111/bph.13348 · DOI · Paper page
- 10.1016/j.echo.2014.10.003 · DOI · Paper page
- 10.1016/j.echo.2016.01.011 · DOI · Paper page
- 10.1111/bcp.13254 · DOI
- 10.1016/j.jacc.2015.07.067 · DOI · Paper page
- 10.1016/j.jacc.2017.05.029 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.107.719591 · DOI · Paper page
- 10.1016/0002-9149(87)90362-6 · DOI
- 10.1016/j.jacc.2011.09.062 · DOI · Paper page
- 10.1016/j.hfc.2007.10.001 · DOI · Paper page
- 10.1161/CIRCIMAGING.109.911438 · DOI
- 10.1161/CIRCIMAGING.109.883652 · DOI · Paper page
- 10.1016/j.jash.2017.05.005 · DOI
- 10.1291/hypres.25.837 · DOI
- 10.1093/ehjci/jeu013 · DOI
- 10.1161/01.HYP.0000121223.44837.de · DOI · Paper page
- 10.1016/j.jacc.2007.03.062 · DOI
- 10.1001/jama.2013.905 · DOI · Paper page
- 10.1136/heartjnl-2012-303329 · DOI · Paper page
Cited by
Kapil, V., Khambata, R. S., Jones, D. A., Rathod, K., Primus, C., Massimo, G., Fukuto, J. M., & Ahluwalia, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019240 · Cited by 248
Bescos, R., Gallardo-Alfaro, L., Ashor, A., Rizzolo-Brime, L., Siervo, M., & Casas-Agustench, P. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.010 · Cited by 23
Li, D., Jovanovski, E., Zurbau, A., Sievenpiper, J., Milicic, D., El-Sohemy, A., & Vuksan, V. (2024) · Nutrients · doi:10.3390/nu16173018 · Cited by 3
Metadata
- Authors
- Faconti, L., Mills, C. E., Govoni, V., Gu, H., Morant, S., Jiang, B., Cruickshank, J. K., & Webb, A. J.
- Affiliations
- Department of Clinical Pharmacology School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre London UK
- Department of Nutritional Sciences, School of Life Course Sciences King's College London London UK
- Medicines Monitoring Unit (MEMO) University of Dundee Dundee UK
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2018-11-13
- Volume
- 85
- Issue
- 1
- Pages
- 169-180
- ISSN
- 0306-5251
- 1365-2125
- Cited by
- 30
- References
- 11
- Language
- en
- Funders
- Fukuda Denshi Ltd
- NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomized controlled VaSera trial. https://app.cochat.ai/papers/10.1111/bcp.13783
- The paper
- Faconti, L., Mills, C. E., Govoni, V., Gu, H., Morant, S., Jiang, B., Cruickshank, J. K., & Webb, A. J. (2019). Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomized controlled VaSera trial. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.13783
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.